Revista de Gastroenterología de México. 2020;85(1):42---47
www.elsevier.es/rgmx
REVISTA DE
DE MEXICO
GASTROENTEROLOGIA
´
´
ORIGINAL ARTICLE
Case-control analysis of fundic gland polyps and
proton-pump inhibitors. A pathologist’s perspective
M. Velazquez-Dohorn, C.F. López-Durand, F. Candanedo-González,
E.A. Araujo-Villalvazo, A. Gamboa-Domínguez
*
Departamento de Patología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Received 12 October 2018; accepted 6 February 2019
Available online 20 July 2019
KEYWORDS
Gastric polyp;
PPI;
Proton pump
inhibitor;
Fundic gland polyp;
Mexico;
Case-control analysis
Abstract
Introduction and aim: Adequately preserved slides and tissue blocks in pathology archives,
when re-reviewed and associated with patient charts, are important tools to further assess
prevalence changes and associations of certain pathologies. Our aim was to identify whether
proton-pump inhibitor (PPI) use, dose, and duration of use were associated with gastric polyps
and their phenotypes in a case-control study.
Methods: The slides from patients with a morphologic diagnosis of either hyperplastic polyps or
fundic gland polyps were retrieved from the 1980, 1990, 2000, 2010, and 2016 surgical pathology
files at a tertiary care hospital in Mexico City and re-evaluated. Cases were paired by age and
sex with patients that underwent endoscopy and gastric mucosa biopsy in the same year, with
no evidence of polyps.
Results: A total of 133 (3.8%) patients with gastric polyps were identified from 3,499 gastric
biopsies taken in the abovementioned years and compared with 133 paired controls. Dyspepsia
was more prevalent in the controls (p = 0.002) and abdominal pain was more prevalent in the
patients with gastric polyps (p = 0.001). PPI use (OR 7.7, 95% confidence interval, 4.4-13.3)
and taking more than one PPI medication (OR 4.9, 95% confidence interval, 1.09-22.3) were
significantly associated with the presence of gastric polyps. The fundic gland phenotype in the
oxyntic mucosa was more frequently associated with PPI use (p < 0.042), with a continuous
increase in its prevalence starting in the year 2000 (p = 0.017 for trend).
Conclusion: PPI administration for at least one year was associated with gastric fundic gland
polyps.
© 2019 Asociaci´ on Mexicana de Gastroenterolog´ ıa. Published by Masson Doyma M´ exico S.A. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
Please cite this article as: Velazquez-Dohorn M, López-Durand CF, Candanedo-González F, Araujo-Villalvazo EA, Gamboa-Domínguez A.
Análisis de casos y controles de pólipos de glándulas fúndicas e inhibidores de bomba de protones. La perspectiva de un patólogo. Revista
de Gastroenterología de México. 2019. https://doi.org/10.1016/j.rgmx.2019.02.007.
*
Corresponding author. Departamento de Patología. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Phone: ++ 52 (55)
5487-0900 ext. 7109; 2184.
E-mail address: agamboad@gmail.com (A. Gamboa-Domínguez).
2255-534X/© 2019 Asociaci´ on Mexicana de Gastroenterolog´ ıa. Published by Masson Doyma M´ exico S.A. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).